IEX •
Real Estate •
Real Estate Services •
Quote as of 06/12/2026
Company Profile
IndustryReal Estate Services
SectorReal Estate
ExchangeIEX
Market Capitalization116.48 mln
Float35.58 mln
Earnings Date06/10/2026
Piotroski F-Score
5
/ 9
Neutral
Beneish M-Score
-2.47
Borderline
Relative Strength
100
/ 100
Top performer
Debt / Equity
0.01
Debt-free
ROE
-39.25
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Rafael Holdings is a US-based company focused on developing treatments for cancer and rare diseases, with additional interests in medical devices and real estate. Its most advanced drug candidates target cancer metabolism and Niemann-Pick Disease Type C1, a rare and fatal genetic condition, both of which are currently in clinical trials. The company also develops specialized surgical tools and holds real estate assets, operating across its home market and Israel.
